CYM5520

CYM5520 is a potent and selective small-molecule agonist of the sphingosine-1-phosphate receptor 2 (S1PR2), with an EC50 of approximately 480 nM. It was developed as a pharmacological tool to investigate the specific signaling pathways mediated by S1PR2, which are distinct from those of other S1P receptor subtypes (S1PR1, 3, 4, and 5). Unlike the endogenous ligand sphingosine-1-phosphate (S1P), CYM5520 is a non-lipid molecule, making it a valuable probe for in vitro and in vivo studies. Research has demonstrated that CYM5520 can activate S1PR2 to regulate various cellular processes, including lipid metabolism in hepatocytes and the proliferation of certain pancreatic cancer cell lines. In preclinical models of pancreatic cancer, activation of S1PR2 by CYM5520 has been shown to aggravate metastatic progression, suggesting that this receptor may be a potential therapeutic target for inhibition in specific oncology contexts.